Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: Humana is a major health benefits company offering insurance products for government-sponsored programs (Medicare, TRICARE, Medicaid) and commercial employer groups. As of June 30, 2007, the company served approximately 11.3 million medical members and 1.9 million specialty product members.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2007 | Six Months Ended June 30, 2007 |
|---|---|---|
| Total Revenues | $6,426.8 million | $12,631.6 million |
| Net Income | $216.8 million | $288.1 million |
| Diluted EPS | $1.28 | $1.70 |
| Operating Cash Flow | N/A | $2,051.7 million |
| Cash and Equivalents | $3,720.8 million (Balance Sheet) | $3,720.8 million (Balance Sheet) |
| Long-Term Debt | $1,189.6 million | $1,189.6 million |
| Medical Expense Ratio (MER) | 83.4% | 85.1% |
| SG&A Expense Ratio | 13.0% | 13.2% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 18.2% for the quarter and 25.0% for the six-month period compared to 2006. This was driven primarily by a 27.5% increase in Government segment premiums (due to Medicare expansion) which offset a 3.6% decline in Commercial segment premiums.
- Profitability: Net income for the quarter more than doubled to $216.8 million from $89.5 million in the prior year quarter. The prior year period included a one-time $51.7 million gain from the sale of a venture capital investment.
- Membership: Total medical membership grew 2.4% to 11.3 million. Medicare Advantage membership increased 18.1%, while fully-insured commercial membership decreased 7.8%.
- Efficiency: The consolidated Medical Expense Ratio (MER) improved by 170 basis points to 83.4% for the quarter. The SG&A expense ratio improved by 70 basis points to 13.0%.
- Liquidity: Cash and cash equivalents increased significantly to $3.72 billion, largely due to the early receipt of July Medicare premiums and strong operating cash flows.
Guidance, Outlook, and Risks
- Outlook: Management expects the consolidated SG&A expense ratio to remain in the 13% to 14% range for the full year 2007. The Government segment's MER is expected to decline in the second half of 2007 due to the seasonal nature of Medicare Part D benefits.
- Acquisitions: Humana agreed to acquire CompBenefits Corporation for approximately $360 million (pending regulatory approval) and completed the acquisition of DefenseWeb Technologies for $26.9 million.
- Regulatory Actions: On June 15, 2007, Humana voluntarily suspended marketing of individual Medicare PFFS products pending a CMS review of compliance requirements.
- Risks: Key risks include medical cost inflation, changes in government reimbursement rates (particularly for Medicare and TRICARE), regulatory scrutiny of business practices, and the potential loss of government contracts. The company faces uncertainty regarding the renewal of Medicaid contracts in Puerto Rico.
Investor Verification Checklist
- Medicare PFFS Suspension: Verify the timeline and potential impact of the voluntary suspension of individual Medicare PFFS marketing on future enrollment growth.
- CompBenefits Acquisition: Monitor the regulatory approval status and closing date of the $360 million CompBenefits acquisition.
- Medical Cost Trends: Review the sustainability of the improved Medical Expense Ratio (MER) given the company's projection of 4.5% to 5.0% medical cost inflation for 2007.
- Government Contract Renewals: Assess the status of the Puerto Rico Medicaid contract renewal process and the upcoming TRICARE contract bidding scheduled for late 2007.
- Cash Flow Timing: Note that the significant increase in operating cash flow was partially driven by the timing of the July Medicare premium receipt; verify if this timing effect will persist in future quarters.